1. Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation Has Unique Features and an Association with Engrafting Unit-to-Recipient HLA Match 
D.M. Ponce, A. Gonzales, M. Lubin, H. Castro-Malaspina, S. Giralt, J.D. Goldberg, A.M. Hanash, A. Jakubowski, R. Jenq, E.B. Papadopoulos, M.A. Perales, M.R.M. van den Brink, J.W. Young, F. Boulad, R.J. O'Reilly, S. Prockop, T.N. Small, A. Scaradavou, N.A. Kernan, C.E. Stevens, J.N. Barker 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 6, Pages (June 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of grades II to IV and III to IV aGVHD at day 180. The incidence is reported at day 180 to include 2 patients with late-onset aGVHD between days 100 and 180 after DCBT and 3 patients who developed aGVHD before day 100 but peaked at grades III to IV disease after day 100. These latter 3 patients, although grade II at onset, are included in the III-IV curve.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Cumulative incidence of GVHD in engrafted and disease-free at 100 days after transplantation. (A) Cumulative incidence of any active GVHD after day 100. (B) Exclusively cGVHD (classic and overlap) after day 100 in this patient population.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Cumulative incidence of day 180 grades III to IV aGVHD by engrafting unit–recipient match at HLA-A,-B,-DRB1 (A) and HLA-A,-B,-C,-DRB1,-DQ (B) alleles.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions